Skip to main content

Featured

TSX Down About 8% in a Week: Should You Tax-Loss Sell Before the Dec. 30 Deadline?

  Canadian Money Brief • Year-End Tax Planning • Nov. 21, 2026 If you opened your brokerage app this week and winced, you are not alone. The S&P/TSX composite closed Friday at 33,189.85, down 838.88 points (about 2.5%) on the day, according to The Canadian Press. A week earlier it closed at 36,105.90, so the index has shed roughly 8% in five trading days. South of the border, the AP reported the S&P 500 fell 3.7% on Friday for its worst weekly loss in more than 18 months, while the Nasdaq slid into negative territory for the year. Painful? Yes. But if you hold investments in a non-registered account, a falling market also hands you a tax tool: tax-loss selling . Used carefully, it can turn a paper loss into a lower tax bill. Used carelessly, it can leave you with no tax benefit at all, or with a portfolio that no longer matches your plan. Here is how it works and what to check before the deadline. THE DEADLINE: Wednesday, Dec. 30, 2026 is the last trading day for most Cana...

article

Provincial Directive Curbs AHS Authority Over Private Surgical Contract Negotiations

 


In a significant policy shift, Alberta Health Minister Adriana LaGrange has stripped Alberta Health Services (AHS) of its authority to negotiate contracts with private surgical facilities. According to a government directive obtained by media, the change came after internal concerns—raised by the agency’s then-chief executive—over rising contract costs.

Documents, including a letter from former AHS CEO Athana Mentzelopoulos’s lawyer, allege that senior government officials—even involving Premier Danielle Smith’s former chief of staff—intervened in AHS’s procurement process to favor private companies. This interference reportedly undermined AHS’s established negotiation powers and raised serious questions about transparency in the province’s health system. 

A separate report in a Morning Update from Unpublished Newswire reiterated the move, noting that the directive is part of broader reforms aimed at reducing costs by leveraging competitive pricing in surgical services.  Meanwhile, a CityNews investigation has added context to the controversy, citing denials by private surgical providers who label the allegations of sweetheart deals as “false and baseless.” 

Critics and opposition leaders are calling for further inquiry into the decision-making process behind these changes, arguing that the shift could signal a move toward greater privatization of public health services. In contrast, government representatives insist that the directive is intended solely to improve efficiency and ensure more competitive pricing for publicly funded operations.

Comments